Atrial fibrillation is the most common sustained cardiac arrhythmia in clinical practice and conveys a 4- to 5-fold increased risk of stroke; yet, it often goes undiagnosed and untreated in a primary care setting. In the program, Dr. Ty Gluckman discusses how to recognize patients at high risk for AF, evaluate patients newly diagnosed with AF, assess risk of bleeding and thromboembolism, and apply evidence-based recommendations to reduce thromboembolic risk. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 8/4/2020, and they are subject to change as new information is published.
The Role of Anticoagulation in Treating Patients with Atrial Fibrillation: A Practical Approach (Recorded at Pri-Med West)
This talk will cover indications for anticoagulation in atrial fibrillation, matters of bridging, and anticoagulant choice based on pharmacology and availability of anticoagulation reversal.
In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th 2020 and they are subject to change as new information is published.
Heart failure is a global pandemic that continues to increase in prevalence. Despite the availability of established and novel therapies, mortality and morbidity in heart failure remains high. Join us for this overview of heart failure classification and pathophysiology, the evidence base supporting various treatments, and current guideline recommendations. Despite being the most common sustained arrhythmia in practice, the ideal management strategy for atrial fibrillation remains elusive for many clinicians. Accordingly, this session will review the classification and initial workup of patients with atrial fibrillation, with further discussion of the primary treatment goals. Stroke prevention therapies will be reviewed, along with means to achieve rate and rhythm control. Tune in to learn about ongoing gaps in the care of patients with heart failure and/or atrial fibrillation and how a standardized approach can help improve outcomes.
What do primary care providers need to know to know about diabetes, atrial fibrillation, and mild cognitive impairment? Join endocrinologist Martin Abrahamson, cardiologist Ty Gluckman, and geriatrician Lee Lindquist as they review important questions, they get asked about these three topics!
Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato
Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib.
Join Dr. Ty Gluckman as he dives deeper into the treatment of atrial fibrillation. This program will focus on rate and rhythm control and the pivotal role they play in alleviating symptoms of AF. Dr. Gluckman will discuss factors that would guide clinical decision making towards a strategy that focuses on rate vs rhythm control.